Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 30, pseudogene (RNU1-30P) is a human gene classified as a pseudogene related to the U1 small nuclear RNA family[1][3][6]. U1 small nuclear RNA (snRNA) is an integral component of the spliceosome that recognizes and binds to the 5′ splice site of pre-mRNA, facilitating mRNA splicing[2]. However, RNU1-30P is a pseudogene version: it contains sequence similarity to functional U1 snRNA genes but harbors mutations or sequence features rendering it nonfunctional as an RNA product[4][6]. It does not encode a working RNA or protein, nor does it participate in biological processes like splicing. Instead, such pseudogenes are considered evolutionary remnants, generated by duplication or retrotransposition events, and do not have known biological or pathological roles[4][6]. No drugs, therapeutic strategies, or biomarkers are associated with RNU1-30P. It is not recognized as a therapeutic target or functional molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 30, pseudogene (RNU1-30P).